NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Ratko TA, Belinson SE, Brown HM, et al. Hematopoietic Stem-Cell Transplantation in the Pediatric Population [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Feb. (Comparative Effectiveness Reviews, No. 48.)
This publication is provided for historical reference only and the information may be out of date.
- aGVHD
acute graft vs. host disease
- AHRQ
Agency for Healthcare Research and Quality
- AIHA
autoimmune hemolytic anemia
- ALCL
anaplastic large cell lymphoma
- ALL
acute lymphoblastic leukemia
- Allo
allogeneic
- AML
acute myelogenous leukemia
- ASBMT
American Society for Blood and Marrow Transplantation
- AT/ RT
atypical teratoid/rhabdoid tumor
- ATG
antithymocyte globulin
- Auto
autologous
- BAALC
brain and acute leukemia, cytoplasmic
- BL
Burkitt-like
- BMF
bone-marrow failure
- BMT
bone-marrow transplant
- CAMT
congenital amegakaryocytic thrombocytopenia
- CC
calcinosis cutis
- C-CSF
granulocyte colony-stimulating factor
- CD
Crohn's disease
- CDAI
Crohn's disease activity index
- CDC
Centers for Disease Control and Prevention
- cGVHD
chronic graft vs. host disease
- CI
confidence interval
- CIBMTR
Center for International Bone Marrow Transplant Research
- CML
chronic myelogenous leukemia
- CNS
central nervous system
- COCALD
childhood onset of cerebral adrenoleukodystrophy
- COG
Children's Oncology Group
- CR
complete remission
- Cy
cyclophosphamide
- DAI
disease activity index
- DBA
Diamond Blackfan anemia
- DFS
disease-free survival
- DFS
disease-free survival
- DLBCL
diffuse large B-cell lymphoma
- DM
diabetes mellitus
- DQ
developmental quotient
- DOD
dead of disease
- DOT
dead of treatment
- EBMT
European Group for Blood and Marrow Transplantation
- EDSS
expanded disability status scale
- EFS
event-free survival
- EPC
Evidence-based Practice Center
- ERT
enzyme-replacement therapy
- ES
Evans syndrome
- ESFT
Ewing sarcoma family of tumors
- F
female
- FA
Fanconi anemia
- FFS
failure-free survival
- Flu
fludarabine
- GCT
germ-cell tumor
- GFR
glomerular filtration rate
- GI
gastrointestinal
- GVHD
graft versus host disease
- GVM
graft versus malignancy
- Hb
hemoglobin
- HbF
fetal hemoglobin
- HDC
high-dose chemotherapy
- HL
Hodgkin's lymphoma
- HLA
human leukocyte antigen
- HR
hazard ratio
- HSCT
hematopoietic stem-cell transplant
- HU
hydroxyurea
- ICGG
International Collaborative Gaucher Group
- IIT
intensive insulin therapy
- IPI
international prognostic index
- IQ
intelligence quotient
- IVIG
intravenous immune globulin
- JIA
juvenile idiopathic arthritis
- JCML
juvenile chronic myelogenous leukemia
- JMML
juvenile myelomonocytic leukemia
- JRA
juvenile rheumatoid arthritis
- KQ
Key Question(s)
- L&H
lymphocytic and histiocytic
- LBL
lymphoblastic lymphoma
- LCL
large-cell lymphoma
- LDH
lactate dehydrogenase
- LFS
leukemia-free survival
- LL
lymphoblastic lymphoma
- M
male
- MA
meta analysis
- MALT
mucosa-associated lymphoid tissue
- MDS
myelodysplastic syndrome
- MG
myasthenia gravis
- MLD
metachromatic leukodystrophy
- Mo(s).
month(s)
- MPS
mucopolysaccharidosis
- MRD
matched related donor
- MRD
minimal residual disease
- MRI
magnetic resonance imaging
- MSC
mesenchymal stem cells
- MS
multiple sclerosis
- MSD
matched sibling donor
- MUD
matched unrelated donor
- N, n
number
- NA
not applicable
- NB
neuroblastoma
- NCCN
National Comprehensive Cancer Network
- NHL
non-Hodgkin's lymphoma
- NHLBI
National Heart, Lung, and Blood Institute
- NK
natural killer
- NOS
not otherwise specified
- NR
not reported
- OS
osteosarcoma
- OS
overall survival
- OS
overlap syndrome
- PBSC
peripheral blood stem cells
- PBSCT
peripheral blood stem-cell transplant
- PDQ®
Physician Data Query
- PFS
progression-free survival
- Ph+/-
Philadelphia chromosome positive/negative
- PICOTS
patients, interventions, comparator, outcomes, timing, setting
- PNET
primitive neuroectodermal tumor
- PPMS
primary progressive multiple sclerosis
- PR
partial remission
- PRMS
progressive relapsing multiple sclerosis
- Pt(s)
patient(s)
- PTCL
peripheral T-cell lymphoma
- QOL
quality of life
- RA
refractory anemia
- RAEB
refractory anemia with excess blasts
- RCT
randomized, controlled trial
- RMS
rhabdomyosarcoma
- RR
relative risk
- RRMS
relapsing, remitting multiple sclerosis
- RuSH
Registry and Surveillance System in Hemoglobinopathies
- sAML
secondary acute myelogenous leukemia
- SCD
sickle-cell disease
- SCID
severe combined immunodeficiency
- SCIG
subcutaneous immune globulin
- SCN
severe congenital neutropenia
- SCT
stem-cell transplant
- SDS
Schwachman Diamond syndrome
- SE
standard error
- SLE
systemic lupus erythematosus
- SLEDAI
Systemic Lupus Erythematosus Disease Activity Index
- SPMS
secondary progressive multiple sclerosis
- SS
systemic sclerosis
- SSc
systemic sclerosis
- TBI
total body irradiation
- TEC
Technology Evaluation Center
- TEP
Technical Expert Panel
- TFS
thalassemia-free survival
- TKI
tyrosine kinase inhibitor
- TNF
tumor necrosis factor
- TRM
treatment-related mortality
- Tx
treatment/therapy
- UCB
umbilical cord blood
- URD
unrelated donor
- VEGF
vascular endothelial growth factor
- VLCFA
very long chain fatty acids
- VOD
veno-occlusive disease
- WBC
white blood cell
- WT
Wilms tumor
- Yr(s)
year(s)
- Acronyms and Abbreviations - Hematopoietic Stem-Cell Transplantation in the Pedi...Acronyms and Abbreviations - Hematopoietic Stem-Cell Transplantation in the Pediatric Population
- pancreatic polypeptide prohormone precursor [Mus musculus]pancreatic polypeptide prohormone precursor [Mus musculus]gi|6679453|ref|NP_032944.1|Protein
- Mesangial hypercellularityMesangial hypercellularityMedGen
Your browsing activity is empty.
Activity recording is turned off.
See more...